Fundraising FoxEpimune Diagnostics
1 known investors
Find your way into Epimune Diagnostics
Sign up to see every warm intro you have to Epimune Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Epimune Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Epimune develops and commercializes epigenetics-based molecular diagnostic tests that quantify immune cells from a drop of blood, aimed at diagnosing and monitoring patients with immune system disorders. Its methods support home blood sampling and dried-blood spot analysis, such as quantifying B cells in patients on anti-CD20 therapies.
Investors · 1
Frequently asked questions
- What does Epimune Diagnostics do?
- Epimune develops and commercializes epigenetics-based molecular diagnostic tests that quantify immune cells from a drop of blood, aimed at diagnosing and monitoring patients with immune system disorders. Its methods support home blood sampling and dried-blood spot analysis, such as quantifying B cells in patients on anti-CD20 therapies.
- Who are Epimune Diagnostics's investors?
- Epimune Diagnostics's investors include Tiburon.